These 5 Medtech CEOs Are the Most Underpaid

September 22, 2015

6 Slides

These 5 Medtech CEOs Are the Most Underpaid

Chris Newmarker

September 22, 2015

Stryker CEO Kevin Lobo’s total compensation was 14th among top executives at 18 of the largest medical device companies publicly traded in the United States. But Stryker comes in fifth for company performance, according to a Qmed analysis of SEC filings.

In other words, Stryker and its shareholders got a bargain when it comes to how Lobo was compensated.

Here at Qmed, we delved into corporate SEC filings to figure out which CEOs arguably get paid less and more than they should, comparing their pay to their companies' financial performance.

We ranked overall compensation for CEOs at 18 of the largest medical device companies publicly traded in the U.S. We then compared the compensation rank with a company performance ranking based on four factors: revenue growth, five-year stock performance compared to the S&P 500, earnings growth, and total revenue (as a control for size).

Here are the five CEOs whose compensation ranking was much lower than the company performance ranking:

Continue>>

Chris Newmarker is senior editor of MPMN and Qmed. Follow him on Twitter at @newmarkerBrian Buntz is the editor-in-chief of MPMN and Qmed. Follow him on Twitter at @brian_buntz.

Like what you're reading? Subscribe to our daily e-newsletter.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like